1,011
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Doppler ultrasound and calcification score: improving vascular access surveillance

, , , &
Pages 1425-1429 | Received 16 Mar 2015, Accepted 24 Jul 2015, Published online: 31 Aug 2015

References

  • Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7:523–535
  • Bittl JA, Cohen DJ, Seek MM, Feldman RL. Economic analysis of angiography and preemptive angioplasty to prevent hemodialysisaccess thrombosis. Catheter Cardiovasc Interv. 2010;75:14–21
  • Pirozzi N, Garcia-Medina J, Hanoy M. Stenosis complicating vascular access for hemodialysis: Indications for treatment. J Vasc Access. 2014;15:76–82
  • Chang CJ, Ko YS, Ko PJ, et al. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int. 2005;68:1312–1319
  • Chang CJ, Ko PJ, Hsu LA, et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: Implication in prevention of restenosis. Am J Kidney Dis. 2004;43:74–84
  • Rotmans JI, Pasterkamp G, Verhagen HJ, Pattynama PM, Blankestijn PJ, Stroes ES. Hemodialysis access graft failure: Time to revisit an unmet clinical need? J Nephrol. 2005;18:9–20
  • Olsson LF, Odselius R, Ribbe E, Hegbrant J. Evidence of calcium phosphate depositions in stenotic arteriovenous fistulas. Am J Kidney Dis. 2001;38:377–383
  • Catalano C, Davi L, Normanno M, Rizzioli E, Conz PA. Vascular calcification of the venous side of an arterious-venous fistula. J Vasc Access. 2001;2:32–34
  • Adragão T, Pires A, Lucas C, et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant. 2004;19:1480–1488
  • Adragão T, Pires A, Birne R, et al. A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant. 2009;24:997–1002
  • Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48:S176–S247
  • Coentrão L, Turmel-Rodrigues L. Monitoring dialysis arteriovenous fistulae: It’s in our hands. J Vasc Access. 2013;14:209–215
  • Ibeas López J. Monitorización del acceso vascular: “Quo vadis”. NefroPlus. 2011;4:11–20
  • Lindsay RM, Blake PG, Malek P, Posen G, Martin B, Bradfield E. Hemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting. Am J Kidney Dis. 1997;30:475–482
  • Bay WH, Henry ML, Lazarus JM, Lew NL, Ling J, Lowrie EG. Predicting hemodialysis access failure with color flow Doppler ultrasound. Am J Nephrol. 1998;18:296–304
  • Ibeas-López J, Vallespín-Aguado J. Ecografía del acceso vascular para hemodiálisis: Conceptos teóricos y prácticos. Nefrologia Sup Ext. 2012;3:21–35
  • Schneditz D, Kaufman AM, Levin N. Surveillance of access function by the blood temperature monitor. Semin Dial. 2003;16:483–487
  • Monroy-Cuadros M, Yilmaz S, Salazar-Bañuelos A, Doig C. Risk Factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol. 2010;5:1787–1792
  • Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Blankestijn PJ. Access blood flow and the risk of complications in mature forearm and upper arm arteriovenous fistulas. Blood Purif. 2009;27:212–219
  • Grandaliano G, Teutonico A, Allegretti A, et al. The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis. Kidney Int. 2003;64:715–719
  • Ifudu O, Mayers JD, Cohen LS, et al. Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients. Am J Nephrol. 1996;16:118–123
  • Huijbregts HJ, Bots ML, Moll FL, Blankestijn PJ. Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas. J Vasc Surg. 2007;45:962–967
  • Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ. Hemodialysis arteriovenous fistula patency revisited: Results of a prospective, multicenter initiative. Clin J Am Soc Nephrol. 2008;3:714–719
  • Roy-Chaudhury P, Arend L, Zhang J, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50:782–790
  • Roy-Chaudhury P, Kelly BS, Miller MA, et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001;59:2325–2334
  • Budu-Grajdeanu P, Schugart RC, Friedman A, Valentine C, Agarwal AK, Rovin BH. A mathematical model of venous neointimal hyperplasia formation. Theor Biol Med Model. 2008;5:2
  • Krueger U, Zanow J, Scholz H. Computational fluid dynamics and vascular access. Artif Organs. 2002;26:571–575
  • Ene-Iordache B, Mosconi L, Remuzzi G, Remuzzi A. Computational fluid dynamics of a vascular access case for hemodialysis. J Biomech Eng. 2001;123:284–292
  • Ocak G, Rotmans JI, Vossen CY, et al. Type of arteriovenous vascular access and association with patency and mortality. BMC Nephrol. 2013;4;14:79
  • Wasse H, Huang R, Naqvi N, Smith E, Wang D, Husai A. Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients. J Vasc Access. 2012;13:168–174
  • Lee T, Somarathna M, Hura A, et al. Natural history of venous morphologic changes in dialysis access stenosis. J Vasc Access. 2014;15:298–305
  • Filippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003;290:353–359
  • Qureshi AR, Alvestrand A, Divino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002;13:S28–S36
  • Dukkipati R, Molnar MZ, Park J, et al. Association of vascular access type with inflammatory marker levels in maintenance hemodialysis patients. Semin Dial. 2014;27:415–423
  • Gagliardi GM, Rossi S, Condino F, et al. Malnutrition, infection and arteriovenous fistula failure: Is there a link? J Vasc Access. 2011;12:57–62
  • Grandaliano G, Teutonico A, Allegretti A, et al. The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis. Kidney Int. 2003;64:715–719
  • Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999;56:383–392
  • Bojakowski K, Dzabic M, Kurzejamska E, et al. High red blood cell distribution width predicts failure of arteriovenous fistula. PLoS One. 2012;7:e36482
  • Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 2002;105:650–655
  • Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102:2636–2642
  • Ram SJ, Magnasco A, Jones SA, et al. In vivo validation of glucose pump test for measurement of hemodialysis access flow. Am J Kidney Dis. 2003;42:752–760

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.